PGR and breast cancer: These results suggest that ER-positive/PR-negative and ER-negative/PR-positive tumors represent 2 biological subtypes distinct from ER-positive/PR-positive and ER-negative/PR-negative BC, although ER-negative/PR-positive tumors are rare.